Kathleen Brady, MD, PhD; Professor of Psychiatry and Behavioral Sciences, Vice President for Research, Medical University of South Carolina (MUSC); Charleston, SC
Deepak Cyril D’Souza, MD; Professor of Psychiatry, Yale University School of Medicine; Director, Schizophrenia Neuropharmacology Research Group at Yale (SNRGY); New Haven, CT
Kelly McGuire, MD, MPA; Assistant Medical Director, Center for Autism and the Developing Brain, New York Presbyterian Hospital. Medical Director, Translational Medicine Program, New York State Psychiatric Institute. Assistant Clinical Professor, Columbia University Department of Psychiatry; White Plains, NY
University of Wisconsin School of Medicine & Public Health Faculty
Marc Kalin, DO; Assistant Professor of Psychiatry
Ned H. Kalin, MD; Hedberg Professor and Chair of Psychiatry
Michael J. Peterson, MD, PhD; Associate Professor, Director of Hospital Psychiatric Services
Anupriya Schnapp, MD; Assistant Professor of Psychiatry
Erick T. Sheftic, MD; Clinical Assistant Professor of Psychiatry
Art Walaszek, MD; Professor of Psychiatry
POLICY ON DISCLOSURE
It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) that the faculty, authors, planners, and other persons who may influence content of this CE activity disclose all relevant financial relationships with commercial interests* in order to allow CE staff to identify and resolve any potential conflicts of interest. Faculty must also disclose any planned discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s).
For this educational activity, all conflicts of interest have been resolved and detailed disclosures are listed below.
* The ACCME defines a commercial interest as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests.